|
Press Releases |
|
|
|
Friday, August 28, 2020 |
|
Sino Biopharm Announces 2020 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2020 (the "review period"). more info >> |
|
Thursday, May 28, 2020 |
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2020 ("the review period"). more info >> |
|
Tuesday, May 26, 2020 |
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration |
Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug more info >> |
|
Tuesday, May 19, 2020 |
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting |
Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab more info >> |
|
Monday, March 30, 2020 |
|
Sino Biopharm Announces 2019 Annual Results |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
Tuesday, January 21, 2020 |
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
Tuesday, November 26, 2019 |
|
Sino Biopharmaceutical Announces 2019 Third Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited third quarterly results for the nine months ended 30 September 2019 ("the review period"). more info >> |
|
Thursday, August 29, 2019 |
|
Sino Biopharmaceutical Announces 2019 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced today its unaudited interim results for the six months ended 30 June 2019 (the "review period").
more info >> |
|
Wednesday, May 22, 2019 |
|
Sino Biopharmaceutical Announces 2019 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2019 ("the review period"). more info >> |
|
Monday, April 1, 2019 |
|
Sino Biopharmaceutical's 2018 Annual Results Reaches New Height |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its annual results for the year ended 31 December 2018. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
All-New Triton Wins Special Award at the RJC Car of the Year for 2025
Nov 12, 2024 22:09 JST
|
|
|
U.S. Polo Assn. Announces an Exclusive Capsule Collection with His Highness Maharaja Sawai Padmanabh Singh of Jaipur, India
Nov 12, 2024 20:00 HKT/SGT
|
|
|
Toyota: HySE to participate in the Dakar 2025 "Mission 1000 ACT2" with the HySE-X2, to tackle further technical challenges
Nov 12, 2024 20:04 JST
|
|
|
AuGroup Landed on the Hong Kong Stock Exchange 'The First Share of Furniture Going Overseas'
Nov 12, 2024 18:29 HKT/SGT
|
|
|
NEC participates in COP29 climate change conference
Nov 12, 2024 19:25 JST
|
|
|
VOY Finance Partners with GDA Capital to Accelerate Growth and Innovation in DeFi Trade Finance
Nov 12, 2024 16:05 HKT/SGT
|
|
|
SIG expands its SIG Neo filling machine portfolio with the global launch of SIG Neo Slimline 15 Aseptic during Gulfood Manufacturing
Nov 12, 2024 16:00 HKT/SGT
|
|
|
The 14th PropertyGuru Asia Property Awards (Singapore) Celebrate Top Real Estate Achievements
Nov 12, 2024 14:30 HKT/SGT
|
|
|
JA Mitsui Leasing and Fujitsu collaborate on simulation-driven field trials to optimize commercial EV adoption and drive decarbonization
Nov 12, 2024 13:57 JST
|
|
|
India's Buyout Advantage: Your Strategic Guide to Acquiring Indian Companies for Market Entry in 2024
Nov 12, 2024 12:04 HKT/SGT
|
|
|
Macnica publishes Integrated Report on the theme of 'An Introductory Guide to Macnica's Mechanism'
Nov 12, 2024 13:00 JST
|
|
|
First Philec Transforms Global Supply Chain with Real-Time Visibility through GoComet
Nov 12, 2024 11:30 HKT/SGT
|
|
|
Interview with Spectral's Sean Brehm on DQLDB the Vogon Cloud
Nov 12, 2024 09:08 HKT/SGT
|
|
|
Spectral Releases its Quantum Bridge Strategy for a Decentralized, Sustainable Future Using Quantum-Resilient Edge Computing
Nov 12, 2024 08:32 HKT/SGT
|
|
|
The First Cold Wallet for Miners: EMCD & Tangem Launching Limited Edition Wallets
Nov 11, 2024 22:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|